Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 262-765-9 | CAS number: 61397-56-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin sensitisation
In a Local Lymph Node Assay (LLNA) in mice (CBA/CaOlaHsd), according to OECD Guideline 429, T001095 did not elicit an SI>= 3 when tested up to a test item concentration of 17% (Honarvar, 2005). Therefore, the test item does not have to be classified as a skin sensitiser and has no obligatory labelling requirement for sensitisation by skin contact according to the CLP Regulation (EC) No. 1272/2008.
An in vitro or in chemico skin sensitisation study does not need to be conducted because adequate data from an in vivo skin sensitisation study (initiated before October 11th 2016) is available.
Respiratory sensitisation
No reliable respiratory sensitisation study was available
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2005-08-25 to 2005-09-21
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- yes
- Remarks:
- : 1) no data on the purity of the test substance was provided. 2) the relative humidity in the animal room was between 30-96%.
- GLP compliance:
- not specified
- Type of study:
- mouse local lymph node assay (LLNA)
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: 00452023 ZT001095PUA121
- Expiration date of the lot/batch: no data
- Purity: no data
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: At room temperature, protected from moisture
- Stability under test conditions: no data
- Solubility and stability of the test substance in the solvent/vehicle:
solubility in vehicle: 210 g/L
- Reactivity of the test substance with the solvent/vehicle of the cell culture medium: no data
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing:
The test item was placed into a volumetric flask glass beaker on a tared balance and the vehicle (DMF) was quantitatively added. The test item concentrations were prepared by serious dilution with DMF using a magnetic stirrer as homogeniser. Homogeneity of the test item in the vehicle was maintained during treatment with the magnetic stirrer.
The preparations were made freshly before each dosing occasion. - Species:
- mouse
- Strain:
- CBA/Ca
- Remarks:
- CBA/CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Netherlands, B.V. Postbus 6174, NL - 5960 AD Horst / The Netherlands
- Age at study initiation: 6-7 weeks (beginning of acclimatization)
- Weight at study initiation: mean: 19.8 +/- 1.3 g (range of 18.4 to 23.5 g)
- Housing: single in Makrolon Type I cages, with wire mesh top (EHRET GmbH, D-79302 Emmendingen) with granulated soft wood bedding (Harlan Winkelmann GmbH, D33178 Borchen)
- Diet: pelleted standard diet, ad libitum (Harlan Winkelman GmbH, D-33178 Borchen)
- Water: tap water, ad libitum (Gemeindewerke, D-64380 Rossdorf)
- Acclimation period: No data on period; however, under test conditions after health examination.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3 °C
- Humidity (%): 30 - 96 %
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): artificial light 6:00 a.m. to 6:00 p.m. - Vehicle:
- dimethylformamide
- Concentration:
- Pre-test: 1.125, 4.25, 8.5 and 17% (w/v)
Main study: 4.25, 8.5, and 17 % (w/v) - No. of animals per dose:
- Pre-test: 2 females (in total)
Main study: 4 females per dose (nulliparous and non-pregnant) - Details on study design:
- PRE-SCREEN TESTS:
- Compound solubility:
- Irritation: in a pre-test in two mice, test substance concentrations of 1.125, 4.25, 8.5, and 17% (w/v) were tested on one ear each. No irritation effects were observed at these concentrations after a single application.
- Systemic toxicity: no data
- Ear thickness measurements: no data
- Erythema scores: no data
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Local Lymph Node Assay
- Criteria used to consider a positive response:
A test substance is regarded as a sensitiser in the LLNA if the following criteria are fulfilled:
1) That exposure to at least one concentration of the test substance resulted in an incorporation of 3HTdR at least 3-fold or greater than that recorded in control mice, as indicated by the stimulation index.
2) That the data are compatible with a conventional dose response, although allowance must be made (especially at high topical concentrations) for either local toxicity or immunological suppression.
TREATMENT PREPARATION AND ADMINISTRATION:
- The test item was placed into a volumetric flask glass beaker on a tared balance and the vehicle (DMF) was quantitatively added. The test substance concentrations were prepared by serious dilution with DMF using a magnetic stirrer as homogeniser. Homogeneity of the test substance in the vehicle was maintained during treatment with the magnetic stirrer. The preparations were made freshly before each dosing occasion. The top dose was the highest technically achievable concentration.
- Each test group of mice was treated by topical (epidermal) application to the dorsal surface of each ear lobe (left and right) with different test substance concentrations of 4.25, 8.5 and 17% (w/v) in DMF. The application volume, 25 µL, was spread over the entire dorsal surface (~ 8 mm diameter) of each ear lobe once daily for three consecutive days. A further group of mice was treated with an equivalent volume of the relevant vehicle alone (control animals). A hair dryer was used to dry the ear's surface as quickly as possible to avoid loss of the test substance applied. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The mean values and standard deviations were calculated for body weights.
A statistical analysis was conducted for assignment of the dose-response relationship, and the EC3 value was calculated according to the equation
EC3 = (a-c)[(3-d)/(b-d)]+c.
EC3 is the estimated concentration of the test substance required to produce a 3-fold increase in draining lymph node cell proliferative activity; (a, b) and (c, d) are respectively the co-ordinates of the two pairs of data lying immediately above and below the S.I. value of 3 on the local lymph node assay response plot. - Positive control results:
- Measured DPM/node: 728.5, 769.3, 1315.8 and 2914.5 respectively for vehicle, test item concentrations 5, 10 and 25% (w/v)
S.I. : 1.06, 1.81 and 4.00, respectively for test item concentrations of 5, 10 and 25% (w/v)
EC3 = 18.2 % (w/v) - Parameter:
- SI
- Value:
- 1.05
- Test group / Remarks:
- 4.25% w/v group
- Parameter:
- SI
- Value:
- 1.16
- Test group / Remarks:
- 8.5% w/v group
- Parameter:
- SI
- Value:
- 1.42
- Test group / Remarks:
- 17% w/v group
- Cellular proliferation data / Observations:
- CELLULAR PROLIFERATION DATA
DPM per lymph node (8 lymph nodes in total):
vehicle: 535.8
4.25% w/v: 560.1
8.5% w/v: 623.0
17% w/v: 759.6
DETAILS ON STIMULATION INDEX CALCULATION
see results table above
EC3 CALCULATION
An EC value was not calculated as the SI values were below 3 in all test groups.
CLINICAL OBSERVATIONS:
No deaths occurred during the study period. No symptoms of local toxicity at the ears of the animals and no systemic findings were observed during the study period.
BODY WEIGHTS
The body weight of the animals, recorded prior to the 1st application and prior to necropsy, was within the range commonly recorded for animals of this strain and age. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- Since there was no indication that the test item elicited a SI ≥ 3 when tested up to a concentration of 17%, it was not considered to be a skin sensitiser. Based on these results, the test item does not have to be classified and has no obligatory labelling requirement for sensitisation by skin contact according to the criteria of the GHS and the CLP Regulation.
- Endpoint:
- skin sensitisation: in vitro
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In a Local Lymph Node Assay (LLNA) in mice (CBA/CaOlaHsd), the skin sensitisation potential of T001095 was investigated following topical application to the dorsal surface of the ear of mice (Honarvar, 2005).
Test item concentrations selected for the main study were based on the results of a preliminary sighting test. Three groups, each of four animals, were treated with 25 μL of the test material (25 μL per ear) as a solution in dimethyl formamide at concentrations of 4.25, 8.5 and 17% w/v. A further group of four animals was treated with dimethyl formamide alone. Clinical observations and checks for mortality were recorded once daily from acclimation start to the termination of in-life phase. Especially the treatment sites were observed carefully. Body weights were recorded on day 1 (prior to first application) and prior to necropsy. The proliferation response of lymph node cells was expressed as the number of radioactive disintegrations per minute per lymph node (dpm/node) and as the ratio of 3HTdR incorporation into lymph node cells of test nodes relative to that recorded for the control nodes (Stimulation Index).
No mortality or signs of systemic toxicity were observed. The mean body weight gain shown by the animals over the study period was considered to be normal. Mean DPM/node (DPM value/8 total lymph nodes) for the experimental groups treated with test item concentrations 4.25, 8.5 and 17% w/v were 560.1, 623.0 and 759.6 respectively. The mean DPM/node value for the vehicle control group was 535.8. The SI values calculated for the substance concentrations 4.25, 8.5 and 17% w/v were 1.05, 1.16 and 1.42, respectively. As T001095 did not elicit a stimulation index (SI) greater than or equal to 3 when tested up to a concentration of 17% w/v, it was considered to be a non-sensitiser under the conditions of the test.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Skin sensitisation:
As the test item did not elicit a stimulation index (SI) greater than or equal to 3 when tested up to 17%, it does not have to be classified as a skin sensitiser and has no obligatory labelling requirement for sensitisation by skin contact according to the CLP Regulation (EC) No. 1272/2008.
Respiratory sensitisation:
No data were available to decide on the classification for respiratory sensitisation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.